Status:
UNKNOWN
The Effects of Individualized Lung-protective Ventilation With Lung Dynamic Compliance-guided Positive End-expiratory Pressure(PEEP) Titration on Postoperative Pulmonary Complications of Pediatric Video-assisted Thoracoscopic Surgery
Lead Sponsor:
Jiaxiang Chen
Conditions:
Anesthesia
Surgery
Eligibility:
All Genders
1-5 years
Phase:
NA
Brief Summary
This study evaluates the influence of individualized lung-protective ventilation strategy(LPVS) on postoperative pulmonary complications(PPCs) through a randomized controlled trial when children under...
Detailed Description
With the advancement of pediatric thoracic surgery techniques, the age group of children who can receive thoracoscopic surgery is getting younger and younger, and even neonates can accept it. In thora...
Eligibility Criteria
Inclusion
- Children undergoing elective thoracoscopic pulmonary surgery.
- Written informed consent.
- Children under 5 years old (including 5 years old)
- ASA classification 1-2
- Respiratory Risk Assessment in Catalan Surgical Patients (ARISCAT) Criteria Low or Moderate Risk
Exclusion
- Symptoms of upper respiratory tract infection or pulmonary infection in the past 4 weeks, chest X-ray suggests pneumonia
- Severe circulatory disease
- Children with bullae
- Intraoperative arterial blood pressure monitoring cannot be performed
- Respiratory Risk Assessment in Catalan Surgical Patients (ARISCAT) Criteria Rated High Risk
Key Trial Info
Start Date :
June 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05386901
Start Date
June 10 2022
End Date
October 1 2024
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzhen Children's Hospital
Shenzhen, Guangdong, China, 518038